Cullinan Oncology, Inc. Profile Avatar - Palmy Investing

Cullinan Oncology, Inc.

Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small mole…

Biotechnology
US, Cambridge [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Cullinan Oncology, Inc. (CGEM) to it's peer group.

Peer Group
Loading...
End of CGEM's Analysis
CIK: 1789972 CUSIP: 230031106 ISIN: US2300311063 LEI: - UEI: -
Secondary Listings
CGEM has no secondary listings inside our databases.